Furthermore, GAS5 over-expression improved DDP therapeutic effects on DDP-resistant osteosarcoma cells, demonstrating that GAS5 enhanced DDP-sensitivity of osteosarcoma in vitro. This evidence concerns the gene GAS5 and osteosarcoma.